Kappris Drug Private Limited
Sells medicines and medical equipment, incorporated in 2019, based in Maharashtra.
2019 | Pune, Maharashtra (India) | Active
Kappris Drug Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 477.88%
- Profit Growth 48.79%
- Ebitda 33.49%
- Net Worth 7.99%
- Total Assets 393.16%
About Kappris Drug
Kappris Drug Private Limited (KDPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 May 2019 (Five years and ten months 0 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Mali, Gorakh Ghadge, and Smith Chavan serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397PN2019PTC183887
- Company No.
183887
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Healthcare
Pharma
Who are the key members and board of directors at Kappris Drug?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Mali  | Director | 02-May-2019 | Current |
| Gorakh Ghadge | Director | 02-May-2019 | Current |
| Smith Chavan | Director | 02-May-2019 | Current |
Financial Performance of Kappris Drug.
Kappris Drug Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 477.88% increase. The company also saw a substantial improvement in profitability, with a 48.79% increase in profit. The company's net worth moved up by a moderate rise of 7.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kappris Drug?
In 2022, Kappris Drug had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kappris Drug?
Unlock and access historical data on people associated with Kappris Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kappris Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kappris Drug's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Kappris Drug
Recent activity within the organization
- Annual General Meeting
Kappris Drug Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Kappris Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
- Director Appointment
Sachin Mahadeo Mali was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 5 years 10 months .
- Director Appointment
Gorakh Tanaji Ghadge was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 5 years 10 months .
- Director Appointment
Smith Suresh Chavan was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 5 years 10 months .
- Company Incorporation
Kappris Drug Private Limited was registered on 02 May 2019 with Roc Pune & aged 5 years 10 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Kappris Drug Private Limited?
Kappris Drug Private Limited was incorporated on 02 May 2019.
What is authorized share capital and paid-up capital of Kappris Drug Private Limited?
The authorized share capital of Kappris Drug Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Kappris Drug Private Limited?
Currently 3 directors are associated with Kappris Drug Private Limited.
- Sachin Mahadeo Mali
- Gorakh Tanaji Ghadge
- Smith Suresh Chavan
What is the registered address of Kappris Drug Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Kappris Drug Private Limited is Flat No E-304 Water Fronts 62/9/1, Ambegaon Kh. India, Pune, Maharashtra, 411046.
What is the corporate identification number (CIN) and company number of Kappris Drug Private Limited?
The corporate identification number (CIN) of Kappris Drug Private Limited is U51397PN2019PTC183887 and the company number is 183887 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Kappris Drug Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Kappris Drug Private Limited has risen by 477.88%.
What change has been observed in the net worth of Kappris Drug Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Kappris Drug Private Limited has experienced an upsurge of 7.99%.
When was the last Balance Sheet of Kappris Drug Private Limited filed with the ROC?
The most recent Balance Sheet for Kappris Drug Private Limited was filed with the ROC on 31 Mar 2024.